Stay updated on Pembrolizumab for High Risk Oral Neoplasia Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.

Latest updates to the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe site version was updated to Revision: v3.4.2 and an older government funding status notice was removed, with no changes to the study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about government funding lapse and NIH operations was added, and the page shows a version update from v3.4.0 to v3.4.1. These updates do not alter the trial details or data presented.SummaryDifference0.4%

- Check28 days agoChange DetectedUI changes include adding a glossary toggle, introducing result-status labels (Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted) and a No FEAR Act Data notice, plus a Revision: v3.4.0; older labels such as Results First Posted (Estimated), Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; there are no changes to study details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a dedicated Locations section listing the Texas site and updated the page revision from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check85 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no substantive changes to the study details are visible.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for High Risk Oral Neoplasia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.